Advanced Search >

Risk Minimisation Materials

MabThera (rituximab) - Important safety information for patients receiving MabThera for non-oncology indications

The information provided in this booklet should be discussed with patients by their healthcare professional during MabThera (rituximab) treatment. This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue